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Abstract
During severe influenza pandemics healthcare demand can exceed clinical capacity to provide normal standards of care.
Community Assessment Tools (CATs) could provide a framework for triage decisions for hospital referral and admission.
CATs have been developed based on evidence that supports the recognition of severe influenza and pneumonia in the
community (including resource limited settings) for adults, children and infants, and serious feverish illness in children. CATs
use six objective criteria and one subjective criterion, any one or more of which should prompt urgent referral and
admission to hospital. A retrospective evaluation of the ability of CATs to predict use of hospital-based interventions and
patient outcomes in a pandemic was made using the first recorded routine clinical assessment on or shortly after admission
from 1520 unselected patients (800 female, 480 children ,16 years) admitted with PCR confirmed A(H1N1)pdm09 infection
(the FLU-CIN cohort). Outcome measures included: any use of supplemental oxygen; mechanical ventilation; intravenous
antibiotics; length of stay; intensive or high dependency care; death; and ‘‘severe outcome’’ (combined: use of intensive or
high dependency care or death during admission). Unadjusted and multivariable analyses were conducted for children (age
,16 years) and adults. Each CATs criterion independently identified both use of clinical interventions that would in normal
circumstances only be provided in hospital and patient outcome measures. ‘‘Peripheral oxygen saturation #92% breathing
air, or being on oxygen’’ performed well in predicting use of resources and outcomes for both adults and children;
supporting routine measurement of peripheral oxygen saturation when assessing severity of disease. In multivariable
analyses the single subjective criterion in CATs ‘‘other cause for clinical concern’’ independently predicted death in children
and in adults predicted length of stay, mechanical ventilation and ‘‘severe outcome’’; supporting the role of clinical acumen
as an important independent predictor of serious illness.
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Introduction
Healthcare demand during severe influenza pandemics can
exceed clinical capacity to provide normal standards of care [1], a
phenomenon now known as ‘‘surge’’. National pandemic
preparedness plans include contingencies for surge capacity
including reducing non-urgent activity and expanding critical
care facilities. [2,3] In exceptional circumstances the use of triage
is recommended to rationalise use of limited hospital resources.
[3].
Assessment tools could provide a framework for consistent and
rational triage decisions pertaining to hospital referral. Ideally,
tools used in the community by a General Practitioner (GP)*
should match hospital admission triage criteria, and be valid
predictors of the likelihood to benefit from use of hospital-based
interventions. [*The term General Practitioner is used in the UK
and some other countries to indicate a registered medical
practitioner specialised in providing acute and chronic care to
people of all ages and sexes in the community and in other
countries may be known as a usual community doctor or primary
care physician.].
During peak pandemic activity, healthcare worker absence is
potentially increased due to personal sickness and caring for
relatives. Imaging and laboratory services may also be limited.
Together these place increased reliance and emphasis on clinical
history-taking and examination skills for triage decisions, which
may be devolved to less experienced staff.
Provisional guidance [4] suggested the use of the CURB-65
pneumonia score [5] and the Pandemic Medical Early Warning
Score (PMEWS) [6] for hospital triage of adults in the UK.
Importantly, neither score was ever intended for use in children.
Most children can benefit from access to adult critical care
facilities and general intensive care units either if they are unlikely
to need transfer to a paediatric intensive care unit (PICU), or if in
extreme circumstances there is no PICU capacity.
Recognising this gap, a ‘‘tool-kit’’ of national guidance was
developed in 2008 in the UK which included newly developed
Community Assessment Tools (CATs) for both children (Appendix
S1) and adults (Appendix S2) in primary and secondary care, and
matched hospital care pathways. [3,7] CATs were designed to
help front-line staff identify sick children and adults most likely to
benefit from hospital care during pandemic surge periods.
Although not specific to influenza, they nevertheless address the
most likely modes of critical illness arising from the disease or its
complications. Criteria fields are common to adult and paediatric
CATs, however specific physiological thresholds and definitions
(e.g. respiratory rate) are age-appropriate.
CATs use six objective criteria and one subjective criterion, any
one or more of which should prompt urgent referral and
admission to hospital (see Appendices 1 & 2). The evidence base
for the objective criteria is that which supports the recognition of
severe influenza and severe pneumonia in the community
(including resource-limited settings) for adults and children, severe
chronic obstructive pulmonary disease in adults, serious feverish
illness in children and severe bronchiolitis in infants. [5,8–17]
Evidence has recently been published supporting use of subjective
criteria in children [18].
The concept was developed by a group at Alder Hey Children’s
Hospital NHS Foundation Trust Liverpool UK (Appendix S3), as
part of an integrated package of care, which included community
and hospital pathways. The pathways provide safety measures for
people who are moderately unwell or who may have other
diagnoses but cannot be admitted to hospital at the time of triage.
The CATs and pathways were further developed by paediatric
and adult expert clinical development groups and published by the
Department of Health (England) for use by the National Health
Service. [3] Clinicians were, and are, warned not to use the CATs
and the pathways unless the local situation precludes normal
admission and discharge processes.
During the somewhat mild 2009–10 influenza pandemic in the
UK, some local areas came under surge pressure, especially for
critical care, but overall national clinical capacity was not
exceeded and CATs and surge pathways were not implemented.
Notwithstanding, data collected by the UK Influenza Clinical
Information Network (FLU-CIN) cohort provided an opportunity
for a retrospective evaluation of the predictive ability of CATs in a
pandemic scenario.
Methods
FLU-CIN was an emergency surveillance study established by
the Department of Health England. The details of data collection
and the findings have been described elsewhere. [19] In brief
FLU-CIN used a purposive sampling frame based on 13 sentinel
hospitals situated in five clinical ‘hubs’ in Nottingham, Leicester,
London, Sheffield and Liverpool, with contributions from a
further 45 non-sentinel hospitals in England and 17 in Scotland,
Wales and Northern Ireland. Between April 2009 and January
2010, clinico-epidemiological and outcome data were collected on
1520 patients (800 female, 480 children ,16 years) admitted to
participating UK hospitals with A(H1N1)pdm09 infection, con-
firmed by reverse transcribed polymerase chain reaction (PCR) of
respiratory samples obtained during the admission episode. Table 1
summarises socio-demographic characteristics of the FLU-CIN
cohort. The clinical characteristics of the FLU-CIN cohort have
been described elsewhere. [20] This was a case-control analysis
using retrospective data from the full FLU-CIN cohort data.
Criterion data were gathered from routine case notes using the
first recorded routine clinical assessment on or shortly after
admission.
We investigated the association between each CATs criterion
(separately) and the use of hospital-based clinical interventions as
well as patient outcomes. Next, we used multivariable logistic
regression modelling to identify which of the CATs criteria were
independent predictors of the use of clinical interventions and
patient outcomes. All criteria were included in the multivariable
model in the first instance irrespective of statistical significance.
Thereafter, we used an automatic stepwise forward selection
approach (threshold for selection p,0.05) to compare the resultant
multivariable model with our original approach.
The CATs criteria are:
A) severe respiratory distress,
B) increased respiratory rate,
C) oxygen saturation #92% on pulse oximetry breathing air, or
‘‘on oxygen’’,
D) respiratory exhaustion,
E) evidence of severe clinical dehydration or clinical shock,
F) altered consciousness level and
G) causing other clinical concern to the patient’s GP or clinical
team.
All criteria were validated using separately recorded clinical
observations made by regular clinical staff on or shortly after
admission.
Outcome measures included clinical interventions and patient
outcomes: any use of supplemental oxygen; mechanical ventila-
tion; intravenous antibiotics; length of stay (categorised as .48
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hours; $6 days and $12 days); higher levels of care (high
dependency – level 2 or intensive care – level 3*); death; and
‘‘severe outcome’’ defined by a composite of any use of higher
levels of care (levels 2 or 3) or death during admission. [*Level 0:
patients whose care needs can be met through normal ward care;
level 1: patients at risk of deteriorating or recently relocated from
higher levels of care whose needs can be met on an acute ward
with additional advice and support from the critical care team;
level 2: patients requiring more detailed observation or interven-
tion, including support for a single failing organ system and those
‘stepping down’ from higher levels of care high dependency unit;
level 3: patients requiring advanced respiratory support alone or
basic respiratory support together with support of at least two
organ systems. This includes all complex patients requiring
support for multi-organ failure in intensive care units].
Analyses were conducted separately for children (age,16 years)
and adults ($16 years). Results are presented as unadjusted and
adjusted odds ratio (OR) with 95% confidence intervals (95%CI)
and p values. The OR describes the likelihood of a given outcome
when an individual CAT criterion is positive. This was a
secondary data analysis based on pragmatic recording of routine
clinical assessments by regular clinical staff. The underpinning
assumption is that the data recorded on presence of criteria was
complete; however there is no way to verify this. By default, where
a criterion was not recorded as being present, that criterion was
assumed to be absent i.e. ‘‘If it isn’t in the notes it didn’t happen’’.
[21] Thus there are no missing data in the analysis. All analyses
were carried out using Stata version 11.0 (StataCorp. 2009. Stata
Statistical Software: Release 11.0; Stata Corporation, College
Station, TX, USA).
Ethics Statement
The Ethics and Confidentiality Committee of the National
Information Governance Board for Health and Social Care in
England approved FLU-CIN procedures before commencement
of the study. The collection of data for the FLU-CIN database has
been publicly funded and, as a public good, will be made available
for new research purposes on a case-by-case basis. In general, only
anonymised data will be supplied to researchers, except where the
law permits the processing of identifiable data. Ownership and
oversight of data access and use resides with the Pandemic
Influenza Preparedness Team at the Department of Health,
England. Any requests for access to FLU-CIN data should be
made to Department of Health via the project leader, Prof JS
Nguyen-Van-Tam (jvt@nottingham.ac.uk).
Results
The unadjusted analysis investigating the association between
each CATs criterion at admission (separately) and outcome
measures (hospital-based intervention and patient outcomes) are
presented for children (,16 years) in Table 2 and for adults ($16
years) in Table 3. The distribution of study subjects meeting each
criterion, tabulated by every outcome measure is reported in
Table S1.
Table 1. Demographic characteristics of 1520 UK patients hospitalised with pandemic H1N1 infection during the 2009/10
pandemic (The FLU-CIN Cohort) compared with source population and pre-pandemic hospital data on acute respiratory infection
admissions.
Demographic characteristic n (%) UK Population, %
Pre-pandemic, acute respiratory
infections*, %
Sex{ Male 720 (47.4) 48.7 50.4
Female 800 (52.6) 51.3 49.6
Age (years)` ,1 121 (8.0) 1.3 14.7
1–4 138 (9.1) 4.8 12.6
5–15 221 (14.5) 12.6 4.8
16–24 245 (16.1) 12.1 2.5
25–34 242 (15.9) 12.9 3.3
35–44 195 (12.8) 14.6 4.6
45–54 168 (11.0) 13.5 5.4
55–64 115 (7.6) 11.8 7.9
65–74 55 (3.6) 8.5 11.0
.75 20 (1.3) 7.8 33.2
Ethnicity`` White 630 (41.5) 92.1 83.3
Mixed 11 (0.7) 1.2 1.9
Asian/Asian British 249 (16.4) 4.0 8.7
Black/Black British 129 (8.5) 2.0 3.4
Chinese and other 121 (8.0) 0.8 2.7
Ethnicity missing 380 (25.0) – –
Data are numbers (%), unless otherwise indicated.
{Census 2001 Data for comparison of sex (KS01 tables) were obtained from the Office for National Statistics (ONS) (www.statistics.gov.uk). `Demographic data on age
distribution based on 2009 mid-year population estimates, ONS.
``Ethnicity data from ONS (Census 2001 data, 2001 data from the General Register Office for Scotland and Northern Ireland Statistics and Research Agency). *Hospital
Episodes Statistics (HES) data: primary discharge codes relating to possible influenza admissions (J06, J10, J11, J13–22) were considered for the pre-pandemic influenza
active period Nov 2008-Mar 2009.
doi:10.1371/journal.pone.0075384.t001
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Criterion A: In children and adults ‘‘Severe respiratory distress’’
was significantly associated with use of supplemental oxygen, use
of mechanical ventilation, length of stay.48 hours &$6 days and
severe outcome (level 2/3 admission and or death). In children
‘‘Severe respiratory distress’’ was also significantly associated with
death, and in adults with use of intravenous antibiotics and length
of stay $12 days.
Criterion B: In children and adults ‘‘Increased respiratory rate’’
was significantly associated with use of supplemental oxygen and
length of stay ($6 & $12 days). In adults ‘‘increased respiratory
rate’’ was also significantly associated with use of mechanical
ventilation. Increased respiratory rate was significantly associated
with a decreased likelihood of intravenous antibiotic use in both
children.
Criterion C: In children and adults ‘‘Peripheral oxygen
saturation #92% breathing air, or on oxygen’’ was significantly
associated with mechanical ventilation, intravenous antibiotic use,
length of stay (.48 hours and $6 days) and severe outcome. In
adults ‘‘Peripheral oxygen saturation #92% breathing air or on
oxygen’’ was also significantly associated with length of stay ($12
days) and death. Use of supplemental oxygen as an outcome
measure was excluded ad oculos from this analysis, as peripheral
oxygen saturation #92%, would with few exceptions trigger
oxygen supplementation in adults and children. [5].
Criterion D: It was not possible to calculate odds ratios for
‘‘Respiratory exhaustion or apnoea’’ in children due to insufficient
cases meeting this criterion. In adults ‘‘Respiratory exhaustion or
apnoea’’ was significantly associated with use of supplemental
Figure 1. CAT criteria as independent predictors of use of oxygen, mechanical ventilation and severe outcomes in children.
Multivariable analyses by forward stepwise regression of CAT criteria as independent predictors of use of oxygen [upper panel], mechanical
ventilation [middle panel] and combined severe outcomes (level 2/3 admission or death)[lower panel] in children (,16 years).
doi:10.1371/journal.pone.0075384.g001
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oxygen, mechanical ventilation, increased length of stay ($6 &
$12 days), severe outcome and death.
Criterion E: In children and adults ‘‘Severe clinical dehydration
or shock’’ was significantly associated with use of mechanical
ventilation, severe outcome and death. In adults ‘‘Severe clinical
dehydration or shock’’ was also significantly associated with use of
supplemental oxygen, intravenous antibiotics and length of stay
($6 & $12 days).
Criterion F: In children and adults ‘‘Altered conscious level’’
was significantly associated with use of supplemental oxygen,
mechanical ventilation, severe outcome and death. In adults
‘‘altered conscious level’’ was also associated with intravenous
antibiotic use and length of stay ($6 & $12 days).
Criterion G: In children and adults the subjective criteria
‘‘Causing other clinical concern’’ was associated with intravenous
antibiotic use and severe outcome. In children ‘‘causing other
clinical concern’’ was also significantly associated with death, and
in adults with length of stay ($6 days). The most frequent
examples of meeting this criterion included in children: fever alone
or in combination with rash or mottled skin or pain or cough; and
in adults: chest pain, fever alone or in combination with cough or
pain.
Figure 2. CAT criteria as independent predictors of use of oxygen, mechanical ventilation and severe outcomes in adults.
Multivariable analyses by forward stepwise regression of CAT criteria as independent predictors of use of oxygen [upper panel], mechanical
ventilation [middle panel] and combined severe outcomes (level 2/3 admission or death)[lower panel] in adults ($16 years).
doi:10.1371/journal.pone.0075384.g002
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Summary results of multivariable analyses using the automatic
stepwise forward selection procedure of CATs criteria at admission
as independent predictors of outcomes (hospital-based intervention
and patient outcomes) in children and adults are presented in
Tables 4 & 5, and in Figures 1 & 2. Results were very similar when
all criteria were retained in the model (Tables S2 & S3).
In children, use of supplemental oxygen was independently
positively predicted by criteria A ‘‘Severe respiratory distress’’ and
F ‘‘Altered conscious level, while association with criterion B
‘‘Increased respiratory rate’’ was weaker (Figure 1 upper panel).
Use of mechanical ventilation was independently predicted by
criteria C ‘‘Peripheral oxygen saturation #92% in air or being on
oxygen’’, E ‘‘Severe clinical dehydration or shock’’, and F ‘‘Altered
conscious level’’, while association with criterion A ‘‘Severe
respiratory distress’’ was weaker (Figure 1 middle panel). Decision
to use intravenous antibiotics was predicted by criterion C
‘‘Peripheral oxygen saturation #92% on air or being on oxygen’’
but negatively predicted by criterion B ‘‘Increased respiratory
rate’’ (Table 4). Length of stay .48 hours was independently
predicted by criteria C. Length of stay $6 days was independently
predicted by criteria B and C. Length of stay $12 days was
independently predicted by criterion B (Table 4). Severe outcome
(level 2/3 care or death) was predicted by criteria A ‘‘Severe
respiratory distress’’, C ‘‘Oxygen saturation #92%’’, E ‘‘Severe
clinical dehydration or shock’’ and F ‘‘Altered conscious level’’
(Figure 1 lower panel). Of note, mortality was only independently
predicted in children by criteria G ‘‘Other clinical concern’’ [OR
(95%CI); 4.24(1.33–13.47), p = 0.014] (Table 4).
In adults use of supplemental oxygen was independently
positively predicted by criteria A ‘‘Severe respiratory distress’’, B
‘‘Increased respiratory rate’’, D ‘‘Respiratory exhaustion’’, F
‘‘Altered conscious level’’ and negatively by G ‘‘Other clinical
concern’’ (Figure 2 upper panel). Use of mechanical ventilation
was independently positively predicted by criteria B ‘‘Increased
respiratory rate’’, C ‘‘Oxygen saturation #92%’’, D ‘‘Respiratory
exhaustion’’, E ‘‘Severe dehydration or shock’’, F ‘‘Altered
conscious level’’ and G ‘‘Other clinical concern’’ (Figure 2 middle
panel). Intravenous antibiotic use was independently predicted by
criteria A, C, and F, but negatively predicted by criteria B and G
(Table 5). Length of stay .48 hours was independently predicted
by criteria A and C (Table 5). Length of stay $6 days was
independently predicted by criteria B, C, F and G. Length of stay
$12 days was independently predicted by criteria B, C, E and F.
Severe outcome was independently predicted by criteria B
‘‘Increased respiratory rate’’, ‘‘Oxygen saturation #92%’’, D
‘‘Respiratory exhaustion’’, E ‘‘Severe clinical dehydration or
shock’’, F ‘‘Altered consciousness’’ and G ‘‘Other clinical concern’’
(Figure 2 lower panel). Mortality was independently predicted by
criteria B ‘‘Increased respiratory rate’’, C ‘‘Oxygen saturation
#92%’’, and E ‘‘Severe clinical dehydration or shock’’ (Table 5).
Discussion
Hospital capacity and resources are strictly limited during a
pandemic. Each of the CATs criteria had an independent role in
identifying both use of clinical interventions that would in normal
circumstances only be provided in hospital and adverse patient
outcome measures, suggesting that had a ‘‘surge’’ threshold been
reached in the UK during the 2009/10 pandemic, these triage
tools would have been fit for purpose. Based on multivariable
analyses none of the criteria were redundant. This is reassuring
given that criteria A to F were selected for proven performance in
identifying severe illness in previous well regarded studies and all
criteria are recognised in current national and international
guidance. [5,8–17] This also suggests that the potential exists for
creating a simple unweighted scoring system similar to CURB-65
or PMEWS using the CATs criteria. A direct comparison of the
overall performance (whole tool rather than individual criteria) of
CATs, CURB-65 and PMEWS as triage tools using the same
cohort data set is the subject of a related paper. [22] CATs were, if
anything, slightly better performing than CURB-65 and PMEWS
during the first two waves of the 2009/10 pandemic in the UK.
Criteria C – ‘‘Peripheral oxygen saturation #92% breathing
air, or on oxygen’’ performed well (in terms of magnitude of odds
ratio and statistical power) in predicting use of resources and
outcomes across all analyses in both adults and children.
Hypoxaemia is particularly difficult to assess in children by clinical
observation. Our findings support the routine use of age-
appropriate peripheral oxygen saturation measurement in assess-
ing severity of disease in patients of all ages. Given the relatively
low cost of such monitoring equipment, this observation may be
particularly pertinent in terms of resource poor settings in other
countries.
Criterion G – ‘‘Causing other clinical concern to their own GP
or clinical team’’ was developed by a workgroup of experts in
primary care and emergency care. In consensus they insisted on
including a subjective criterion that allowed ‘‘a clinician in
primary care to uses their own judgement to refer a patient to
hospital’’ and ‘‘a clinician in hospital to use their judgement to
admit a patient’’ in cases where other criteria may not have been
met. It might be expected that very many patients would meet this
subjective criterion and that the criterion would have poor
discriminatory power and no validity but quite the opposite was
observed. In multivariate analysis criterion G was the only criteria
that independently predicted death in children. In adults criterion
G independently predicted length of stay $6 days, mechanical
ventilation and combined severe outcome (level 2/3 admission or
death). Meeting this criterion in children was often based on
recognition of fever plus another sign, and in adults recognition of
chest pain or fever plus another sign. This finding supports the role
of clinical judgment, be it founded on acumen, experience or
instinctive ‘‘gut feeling’’, as a important independent predictor of
serious illness in people of all ages. [18].
Limitations
CATs were being developed in preparation for a severe
pandemic event when the A(H1N1)2009 influenza virus emerged.
As a consequence the value of the individual criteria and overall
validity of CATs (content validity, reliability, measurement
properties and ability to detect change) were not tested in a
prospective study as would be expected in an ideal situation. [23]
Instead the CATs were rapidly finalised and made ready for use in
the event of surge. Here we have presented an evaluation of the
potential role of CATs criteria to predict interventions and
outcomes in a pragmatic study conducted during a pandemic
using the extensive data provided by the prospective multicentre
FLU-CIN cohort. By design it was not possible to assess intra-
observer agreement, inter-observer agreement or ability to detect
change.
A potential limitation of this study relates to possible misclas-
sification of criteria. This could happen because of an error in
assessment of the patient by the clinician or because of a failure to
check whether a criterion was actually ‘not present’. This is an
inherent bias in all observational studies using routine clinical data
and there is no way to verify this. However any bias caused by
misclassification of criteria (the independent predictor variable) as
not being present when in reality that criterion is present, will
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minimise differences in comparisons and so where we describe
significant differences, these are likely to be robust.
Generalisability
This study is limited to cases of proven A(H1N1)pdm09
influenza requiring hospital admission. It should be noted that it
was not the aim of this study to derive a clinical predictor tool. CATs
had already been proposed using a conceptual clinical framework
but there were no baseline data on performance in a similar
pandemic situation to enable meaningful validation in the FLU-
CIN surveillance cohort. The aim of this study was, therefore, to
explore the potential applicability of CATs as a clinical triage tool
and contribute to its development in terms of whether the initial
proposal to treat each criterion equally as a stand-alone trigger was
justified. Further work is needed to validate CATs in an external
cohort which could be drawn from other settings during the
previous pandemic period or by means of prospective validation in
future pandemic or epidemic scenarios and to consider using a
combined or weighted scoring strategy. Moreover, it is recognised
that the predictive performance of tools tested in secondary care
settings may not be generalisable to primary care settings. Therefore
the next step will be an assessment of the performance of CATs and
other triage tools in the community.
Morbidity and mortality rates were low during the 2009/10
pandemic when compared to some previous influenza pandemics.
Accordingly, the discriminatory capabilities of CATs might well
differ where a pathogen has greater virulence.
The CATs were developed for use during pandemic events and
their criteria address the most likely modes of critical illness arising
from influenza, or the complications of influenza. CATs were also
designed to identify sick patients most likely to benefit from higher
levels of care due to other illnesses, which at presentation are
indistinguishable from influenza like illness. CATs may have value
in other scenarios where a high triage threshold is required for
both adults and children such as other severe acute respiratory
pandemic events, and possibly in some sudden impact health
emergencies producing mass casualties.
Conclusions
This study shows that CATs are potentially useful predictors of
both use of hospital-based interventions and severe patient
outcomes during an influenza pandemic. Each of the CATs
criteria had a role in predicting a given outcome and none are
redundant. It is also notable and novel that both paediatric and
adults CATs were developed upon a common framework of
assessment. Importantly this confers an element of equity in a
situation where children and adults may have to compete for
access to a limited common resource such as mechanical
ventilators.
The CATs presented in this paper represent the first attempt to
provide frontline healthcare professionals working across a
national health service in communities and hospitals with high
threshold triage criteria that could help make consistent, albeit
difficult, decisions during extreme situations when health care
demand exceeds capacity.
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